Pfizer
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Pfizer (PFE) Business News
Track Pfizer in real time with a live news feed covering Pfizer stock news, official press releases, company announcements, and an archive of historical Pfizer news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
Dana Investment Advisors Inc. Sells 36,261 Shares of Pfizer Inc. $PFE
Pfizer Inc. $PFE Shares Acquired by Andra AP fonden
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
Dana Investment Advisors Inc. Sells 36,261 Shares of Pfizer Inc. $PFE
Pfizer Inc. $PFE Shares Acquired by Andra AP fonden
Retirees Are Quickly Moving Into These Dividend Funds
5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills
This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income
Pfizer Adds Sciwind As China Partner For New Weight Loss Drug
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
Pfizer Inc. $PFE Shares Purchased by Dakota Wealth Management
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
10:00 AM | Friday | Feb 27, 2026
NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced positive results from the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for PADCEVTM (enfortumab vedotin), a Nectin-4 directed antibody-drug conjugate, in combination with Keytruda® (pembrolizumab), a PD-1 inhibitor, in patients with muscle-invasive bladder cancer (MIBC) eligible for cisplatin-based chemotherapy. Perioperative.
Read full article
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
Business WireNEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced positive results from the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for PADCEVTM (enfortumab vedotin), a Nectin-4 directed antibody-drug conjugate, in combination with Keytruda® (pembrolizumab), a PD-1 inhibitor, in patients with muscle-invasive bladder cancer (MIBC) eligible for cisplatin-based chemotherapy. Perioperative.
Read full article
Dana Investment Advisors Inc. Sells 36,261 Shares of Pfizer Inc. $PFE
Defense WorldDana Investment Advisors Inc. lessened its stake in shares of Pfizer Inc. (NYSE: PFE) by 35.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 66,811 shares of the biopharmaceutical company's stock after selling 36,261 shares during the quarter.
Dana Investment Advisors
Pfizer Inc. $PFE Shares Acquired by Andra AP fonden
Defense WorldAndra AP fonden increased its holdings in shares of Pfizer Inc. (NYSE: PFE) by 22.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 996,700 shares of the biopharmaceutical company's stock after acquiring an additional 180,600 shares during the quarter. Andra AP fonden's
Read full article
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
Business WireNEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced positive results from the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for PADCEVTM (enfortumab vedotin), a Nectin-4 directed antibody-drug conjugate, in combination with Keytruda® (pembrolizumab), a PD-1 inhibitor, in patients with muscle-invasive bladder cancer (MIBC) eligible for cisplatin-based chemotherapy. Perioperative.
Read full article
Dana Investment Advisors Inc. Sells 36,261 Shares of Pfizer Inc. $PFE
Defense WorldDana Investment Advisors Inc. lessened its stake in shares of Pfizer Inc. (NYSE: PFE) by 35.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 66,811 shares of the biopharmaceutical company's stock after selling 36,261 shares during the quarter.
Dana Investment Advisors
Pfizer Inc. $PFE Shares Acquired by Andra AP fonden
Defense WorldAndra AP fonden increased its holdings in shares of Pfizer Inc. (NYSE: PFE) by 22.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 996,700 shares of the biopharmaceutical company's stock after acquiring an additional 180,600 shares during the quarter. Andra AP fonden's
Read full article
Retirees Are Quickly Moving Into These Dividend Funds
24/7 Wall StreetShifting from higher-risk assets to consistent income sources is a natural progression for retirees.
Read full article
5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills
Seeking AlphaLong-term bond yields continue to rise. But investors looking for income can still find plenty of attractive opportunities with dividend-paying stocks that have healthy yields. “23 stocks pay huge dividends. They should be a better bet than treasuries.” —Barron's Weekly reported in October, 2024.
Steven Wieting, strategist at Citi Wealth, told Barron's a growing dividend is a tangible-benefit for shareholders and a hallmark of companies with strong balance-sheets. “Nobody can fake a dividend," he-said.
This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income
The Motley FoolPfizer is dealing with headwinds right now, but they aren't unusual headwinds in the pharmaceutical sector. The company is taking aggressive actions to get back on track and recently stated it plans to support its dividend.
Read full article
Pfizer Adds Sciwind As China Partner For New Weight Loss Drug
ForbesIn the latest China pharmaceutical industry collaboration pact with a global drug leader, Hangzhou Sciwind Biosciences said today it had reached an agreement with Pfizer China to team up on the commercialization of a new-generation weight management and diabetes treatment, in a deal worth up to $495 million for the Chinese company.
Read full article
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
GlobeNewsWireThis news release constitutes a “designated news release” for the purpose of the Company's prospectus supplement dated December 30, 2025, to it short form base shelf prospectus dated September 17, 2025, as amended on December 19, 2025.
Read full article
Pfizer Inc. $PFE Shares Purchased by Dakota Wealth Management
Defense WorldDakota Wealth Management grew its stake in shares of Pfizer Inc. (NYSE: PFE) by 33.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 348,386 shares of the biopharmaceutical company's stock after acquiring an additional 87,308 shares during the period. Dakota Wealth Management's holdings in Pfizer
Read full article
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks Investment ResearchPfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read full article